1-9 of 9
Per Boye Hansen
Close
Sort by
Journal Articles

Clinical Impact of Clonal Hematopoiesis after Autologous Stem Cell Transplantation for Lymphoma: A National Population-Based Cohort Study

Simon Husby, MD, Favero Francesco, PhD, Christian Nielsen, PhD, Betina Sørensen, MD, John Bæch, MD, Jakob Werner Hansen, MD, German G.R. Gonzalez, PhD, Bente Arboe, Lisbeth Pernille Andersen, MD, Eva Kannik Hastrup, MD PhD, Anne Fischer-Nielsen, MD PhD, Susanne G Sækmose, MD, Per Boye Hansen, MD, Ilse Christiansen, Erik Clasen-Linde, MD, Lene Meldgaard Knudsen, MD DMSc, Kathrine Grell, PhD, Erik Kay Segel, MD, Lene Hyldahl Ebbesen, MD PhD, Michael Thorsgaard, Pär L. Josefsson, Tarec Christoffer El-Galaly, MD PhD, Peter De Nully Brown, Joachim Weisenfeldt, PhD, Thomas Stauffer Larsen, MD PhD, Kirsten Grønbæk, Professor, MD DMSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 607.
https://doi.org/10.1182/blood-2018-99-109893
Published: 2018
Journal Articles

Nordic MCL3 study: 90 Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

Clinical Trials & Observations
Arne Kolstad, Anna Laurell, Mats Jerkeman, Kirsten Grønbæk, Erkki Elonen, Riikka Räty, Lone Bredo Pedersen, Annika Loft, Trond Velde Bogsrud, Eva Kimby, Per Boye Hansen, Unn-Merete Fagerli, Herman Nilsson-Ehle, Grete Fossum Lauritzsen, Anne Kristine Lehmann, Christer Sundstrom, Marja-Liisa Karjalainen-Lindsberg, Elisabeth Ralfkiaer, Mats Ehinger, Jan Delabie, Hans Bentzen, Jukka Schildt, Kamelia Kostova-Aherdan, Henrik Frederiksen, Peter de Nully Brown, Christian H. Geisler
Journal: Blood
Blood (2014) 123 (19): 2953–2959.
https://doi.org/10.1182/blood-2013-12-541953
Published: 2014
Journal Articles

Nordic MCL3 Study: Zevalin Combined with High-Dose Chemotherapy Followed by Autologous Stem Cell Support As Late Intensification for Mantle Cell Lymphoma (MCL) Patients < 66 Years Not in CR After Induction Chemoimmunotherapy: No Benefit of Zevalin

Kolstad Arne, Anna Laurell, Mats Jerkeman, Kirsten Grønbæk, Erkki Elonen, Riikka Räty, Lone Bredo Pedersen, Annika Loft, Trond Velde Bogsrud, Marie Nordstrøm, Per Boye Hansen, Unn-Merete Fagerli, Herman Nilsson-Ehle, Grete Fossum Lauritzsen, Anne Kristine Lehmann, Christer Sundstrom, Marja-Liisa Karjalainen-Lindsberg, MD, PhD, Elisabeth Ralfkiaer, Mats Ehinger, Jan Delabie, Hans Bentzen, Jukka Schildt, Kamelia Kostova-Aherdan, Henrik Frederiksen, Peter de Nully Brown, Christian H. Geisler
Journal: Blood
Blood (2012) 120 (21): 747.
https://doi.org/10.1182/blood.V120.21.747.747
Published: 2012
Journal Articles

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy

Francesco d'Amore, Sirpa Leppä, Maria Gomes da Silva, Thomas Relander, Peter De Nully Brown, Eckhart Weidmann, Grete Fossum Lauritzsen, Antonio Pezzutto, Achiel Van Hoof, Michel van Gelder, Jeanette K Doorduijn, Ka Lung Wu, MD, PhD, J.C. Kluin-Nelemans, P.J. Lugtenburg, Milada Jankovska, Mats Merup, Unn-Merete Fagerli, Jan Walewski, Hans Hagberg, Jose Mario Mariz, Per Boye Hansen, Thomas Nösslinger, Ann Janssens, Lena Brandefors, Hilde Demuynck, Martyn Ronald Schaafsma, Ilse Christiansen, David Salek, Sirkku Jyrkkiö, Vit Prochazka, Josee Zijlstra, L. Böhmer, Richard Greil, MD, Wendy Stevens, Rob Fijnheer, Marinus van Marwijk Kooy, Matthias Grube, Georg Hopfinger, MD, Eric Van den Neste, Esa Jantunen, Lorenz Trümper, Gerald Wulf, Bettina Altmann, Marita Ziepert, Markus Loeffler, Helle Toldbod
Journal: Blood
Blood (2012) 120 (21): 57.
https://doi.org/10.1182/blood.V120.21.57.57
Published: 2012
Journal Articles

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,

Francesco d'Amore, MD, DMSci, Maria Gomes da Silva, Sirpa Leppa, Thomas Relander, Antonio Pezzutto, Grete F. Lauritzsen, Eckhart Weidmann, Michel Van Gelder, Mats Merup, Hans Hagberg, Unn-Merete Fagerli, Peter de Nully Brown, Per Boye Hansen, Jose Mario Mariz, Milada Jankovska, Jan Walewski, MD, PhD, Jeanette Doorduijn, Achiel Van Hoof, Ilse Christiansen, Sirkku Jyrkkiö, J.C. Kluin-Nelemans, Marinus van Marwijk Kooy, Rob Fijnheer, Wendy Stevens, Josee Zijlstra, L. Böhmer, P.J. Lugtenburg, Matthias Grube, Vit Prochazka, David Salek, Richard Greil, MD, Lorenz Trümper, Gerald Wulf, Bettina Altmann, Marita Ziepert, Markus Loeffler, Esa Jantunen, Georg Hopfinger, Eric Van den Neste, MD, Helle Toldbod
Journal: Blood
Blood (2011) 118 (21): 4110.
https://doi.org/10.1182/blood.V118.21.4110.4110
Published: 2011
Journal Articles

Sufficient and Timely Autologous Stem Cell Harvest After Chemoimmunotherapy with Alemtuzumab In Combination with Bi-Weekly CHOP as First Line Treatment In Systemic Peripheral T-Cell Lymphomas (PTCL): a Feasibility Analysis From the First Randomized Trial In Systemic PTCL (ACT trial)

Francesco d'Amore, Maria Gomes da Silva, Sirpa Leppa, Antonio Pezzutto, Thomas Relander, Grete Fossum Lauritzsen, Eckhart Weidmann, Michel Van Gelder, Jeanette Doorduijn, J.C. Kluin-Nelemans, Marinus van Marwijk Kooy, Rob Fijnheer, Okke de Weerdt, Peter de Nully Brown, Per Boye Hansen, Mats Merup, Matthias Grube, Jose Mario Mariz, Jan Walewski, Lorenz Truemper, Gerald Wulf, Esa Jantunen, Georg Hopfinger, it Prochazka, V
Journal: Blood
Blood (2010) 116 (21): 2395.
https://doi.org/10.1182/blood.V116.21.2395.2395
Published: 2010
Journal Articles

90 y-Ibritumumab Tiuxetan (Zevalin ®)-BEAM/C with Autologous Stem Cell Support as Frontline Therapy for Advanced Mantle Cell Lymphoma. – Preliminary Results From the Third Nordic MCL Phase II Study (MCL3).

Arne Kolstad, Anna Laurell, Niels S Andersen, Erkki Elonen, Riikka Raty, Lone Bredo Pedersen, Annika Loft, Trond Velde Bogsrud, Marie Nordstrom, Dorte Gillstrom, Per Boye Hansen, Hans Bentzen, Unn-Merete Fagerli, Peter Meyer, Herman Nilsson-Ehle, Mats Jerkeman, Anne Kristine Lehmann, Grete F Lauritzsen, Christer Sundstrom, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Elisabeth Ralfkiaer, Mats Ehinger, Christian H. Geisler
Journal: Blood
Blood (2009) 114 (22): 932.
https://doi.org/10.1182/blood.V114.22.932.932
Published: 2009
Journal Articles

Epidemiological and Clinico-Pathological Features of Systemic Peripheral T-Cell Lymphomas (PTCL): A Population-Based Analysis from the Danish Lymphoma Registry LYFO

Francesco d’Amore, MD, Peter de Nully Brown, Lars Moeller Pedersen, Anne Bukh, Per Boye Hansen, Bjarne Bach Pedersen, Ole Gadeberg, Michael Pedersen, Steen Ingeberg, Stanislaw Pulczynski, Torben Mourits Andersen, Michael Moeller
Journal: Blood
Blood (2008) 112 (11): 3766.
https://doi.org/10.1182/blood.V112.11.3766.3766
Published: 2008
Journal Articles

Darbepoetin Alfa for the Treatment of Anemia in Patients with Myelofibrosis with Myeloid Metaplasia (MMM). Results from a Danish Multicenter Study.

Kathrine Hannestad, Thomas Stauffer Larsen, Torben Mourits Andersen, Niels Aage Toeffner Clausen, Per Boye Hansen, Bjarne Anker Jensen, Henrik Sverre Birgens, Hans Carl Hasselbalch
Journal: Blood
Blood (2007) 110 (11): 4641.
https://doi.org/10.1182/blood.V110.11.4641.4641
Published: 2007